Complementary meds used by 17 percent of elderly with cancer

March 2, 2012
Complementary meds used by 17 percent of elderly with cancer

(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional status, according to a study published online Feb. 22 in Cancer.

Ronald J. Maggiore, M.D., of the University of Chicago Medical Center, and colleagues evaluated the prevalence of complementary medicine use as well as factors associated with its use among 545 patients (mean age, 73 years) about to start chemotherapy for cancer (61 percent stage IV).

The researchers found that 17 percent of patients reported using at least one complementary medication, with a mean of two medications used per patient. There was an association between complementary medication use and earlier (stage I to II, 29 percent; stage III to IV, 17 percent; odds ratio [OR], 2.05) as well as less impairment in instrumental activities of daily living (OR, 1.39).

"Complementary medication use was reported by 17 percent of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status," the authors write. "Further studies are needed to determine the association between complementary medication use and cancer outcomes among ."

One of the authors disclosed to the pharmaceutical industry.

Explore further: Study showed oxaliplatin improved colon cancer patient survival

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study showed oxaliplatin improved colon cancer patient survival

January 20, 2012
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published ...

Recommended for you

Researchers identify gene variants linked to a high-risk children's cancer

September 25, 2017
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing ...

Prostaglandin E1 inhibits leukemia stem cells

September 25, 2017
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

September 25, 2017
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...

Cancer vaccines need to target T cells that can persist in the long fight against cancer

September 25, 2017
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

Lung cancer treatment could be having negative health effect on hearts

September 25, 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.